SG Americas Securities LLC Has $712,000 Stock Holdings in Silk Road Medical, Inc (NASDAQ:SILK)

SG Americas Securities LLC increased its position in shares of Silk Road Medical, Inc (NASDAQ:SILKGet Rating) by 44.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,815 shares of the company’s stock after acquiring an additional 4,858 shares during the period. SG Americas Securities LLC’s holdings in Silk Road Medical were worth $712,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in the company. Raymond James & Associates lifted its stake in Silk Road Medical by 23.0% in the 1st quarter. Raymond James & Associates now owns 17,672 shares of the company’s stock valued at $730,000 after purchasing an additional 3,304 shares during the last quarter. US Bancorp DE raised its stake in shares of Silk Road Medical by 41.3% during the first quarter. US Bancorp DE now owns 1,673 shares of the company’s stock valued at $69,000 after acquiring an additional 489 shares during the last quarter. MetLife Investment Management LLC raised its stake in shares of Silk Road Medical by 63.3% during the first quarter. MetLife Investment Management LLC now owns 18,697 shares of the company’s stock valued at $772,000 after acquiring an additional 7,246 shares during the last quarter. Rhumbline Advisers raised its stake in shares of Silk Road Medical by 4.7% during the first quarter. Rhumbline Advisers now owns 35,607 shares of the company’s stock valued at $1,470,000 after acquiring an additional 1,584 shares during the last quarter. Finally, BlackRock Inc. raised its stake in shares of Silk Road Medical by 1.2% during the first quarter. BlackRock Inc. now owns 2,556,071 shares of the company’s stock valued at $105,542,000 after acquiring an additional 29,112 shares during the last quarter. Institutional investors and hedge funds own 96.43% of the company’s stock.

Silk Road Medical Price Performance

Shares of NASDAQ SILK opened at $53.64 on Friday. Silk Road Medical, Inc has a twelve month low of $27.21 and a twelve month high of $58.04. The firm has a fifty day simple moving average of $52.92 and a 200 day simple moving average of $46.73. The company has a market capitalization of $2.04 billion, a PE ratio of -32.91 and a beta of 1.24. The company has a quick ratio of 5.29, a current ratio of 6.14 and a debt-to-equity ratio of 1.30.

Silk Road Medical (NASDAQ:SILKGet Rating) last posted its quarterly earnings results on Tuesday, November 8th. The company reported ($0.29) EPS for the quarter, topping analysts’ consensus estimates of ($0.44) by $0.15. The business had revenue of $37.37 million during the quarter, compared to analysts’ expectations of $33.84 million. Silk Road Medical had a negative net margin of 45.16% and a negative return on equity of 86.73%. On average, sell-side analysts forecast that Silk Road Medical, Inc will post -1.57 EPS for the current year.

Insiders Place Their Bets

In other Silk Road Medical news, Director Tony M. Chou sold 10,060 shares of the firm’s stock in a transaction on Tuesday, December 13th. The shares were sold at an average price of $55.00, for a total value of $553,300.00. Following the completion of the sale, the director now directly owns 88,715 shares in the company, valued at $4,879,325. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, Director Tony M. Chou sold 10,060 shares of Silk Road Medical stock in a transaction dated Tuesday, December 13th. The shares were sold at an average price of $55.00, for a total transaction of $553,300.00. Following the completion of the transaction, the director now directly owns 88,715 shares in the company, valued at $4,879,325. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Lucas W. Buchanan sold 25,000 shares of Silk Road Medical stock in a transaction dated Tuesday, December 13th. The shares were sold at an average price of $55.00, for a total transaction of $1,375,000.00. Following the transaction, the chief financial officer now owns 176,527 shares of the company’s stock, valued at $9,708,985. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 249,118 shares of company stock worth $13,295,585. 7.66% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

SILK has been the subject of several analyst reports. Bank of America initiated coverage on shares of Silk Road Medical in a research note on Tuesday, November 22nd. They set a “buy” rating and a $60.00 price target for the company. Argus raised their price target on shares of Silk Road Medical from $60.00 to $70.00 in a research note on Monday, January 9th. Finally, Citigroup lifted their target price on shares of Silk Road Medical to $38.00 in a research note on Tuesday, November 15th.

Silk Road Medical Profile

(Get Rating)

Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices.

Further Reading

Want to see what other hedge funds are holding SILK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Silk Road Medical, Inc (NASDAQ:SILKGet Rating).

Institutional Ownership by Quarter for Silk Road Medical (NASDAQ:SILK)

Receive News & Ratings for Silk Road Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silk Road Medical and related companies with MarketBeat.com's FREE daily email newsletter.